Tango Therapeutics, Inc.
TNGX· Nasdaq· Pharmaceutical Preparations
- Market cap
- –
- P/FCF
- –
- EV/Sales
- –
- FCF margin
- -224.3%
- ROIC, 5 yr avg
- –
- Revenue, 5 yr CAGR
- +52.1%
We record prices for the companies we cover; TNGX is not one of them yet.
Company statistics
Profile · FY2025
- Market cap
- –
- Enterprise value
- –
- Diluted shares
- 116.2M
- Revenue
- $62.4M
- Free cash flow
- -$139.9M
- Owner earnings
- -$166.4M
Valuation · FY2025
- P/E
- –
- P/FCF
- –
- P/Owner earnings
- –
- EV/Sales
- –
- EV/FCF
- –
- P/B
- –
Margins · FY2025
- Gross
- –
- Operating
- -178.4%
- Net
- -162.9%
- Free cash flow
- -224.3%
- Owner earnings
- -266.7%
- Stock pay
- 42.4%
Returns
- ROIC, FY2025
- –
- ROIC, 5 yr avg
- –
- ROE, FY2025
- -29.3%
- ROE, 5 yr avg
- -39.0%
Growth (CAGR)
- Revenue, 3 yr
- 35.9%
- Revenue, 5 yr
- 52.1%
- Diluted EPS, 3 yr
- –
- Diluted EPS, 5 yr
- –
- Free cash flow, 3 yr
- –
- Free cash flow, 5 yr
- –
Financial health · FY2025
- Cash and investments
- $343.1M
- Total debt
- –
- Net cash
- –
- Debt/Equity
- –
- Debt/FCF
- –
Shareholder returns · FY2025
- Dividend yield
- –
- Payout ratio
- –
- Buyback yield
- –
- Shareholder yield
- –
- Share count, 5 yr
- –
Financials: ten years from the 10-Ks
Revenue
$62.4M
+52.1% a year over 5 years
FY2020FY2025
Margins
Operating-178.4%Net-162.9%
FY2025
FY2020FY2025
Free cash flow and owner earnings
Free cash flow-$139.9MOwner earnings-$166.4M
FY2025
FY2020FY2025
Diluted shares
116.2M
+87.0% over 5 years, net dilution
FY2020FY2025
Every figure, year by year
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| The business | ||||||
| Revenue | $7.7M | $37.0M | $24.9M | $36.5M | $42.1M | $62.4M |
| Revenue growth | – | 383.8% | -32.9% | 46.9% | 15.2% | 48.3% |
| Gross margin | – | – | – | – | – | – |
| Operating margin | -681.8% | -157.1% | -446.8% | -312.6% | -346.1% | -178.4% |
| Net income | -$52.0M | -$58.2M | -$108.2M | -$101.7M | -$130.3M | -$101.6M |
| Net margin | -678.8% | -157.2% | -435.1% | -278.5% | -309.7% | -162.9% |
| Diluted EPS | – | $-0.94 | $-1.23 | $-1.08 | $-1.19 | $-0.87 |
| Return on invested capital? | – | – | – | – | – | – |
| Cash | ||||||
| Operating cash flow | $70.1M | -$59.5M | -$109.1M | -$118.0M | -$131.5M | -$138.9M |
| Capital expenditure | $1.1M | $1.8M | $7.7M | $1.5M | $754.0K | $1.0M |
| Free cash flow | $69.0M | -$61.4M | -$116.8M | -$119.5M | -$132.3M | -$139.9M |
| Stock-based compensation | $1.8M | $7.8M | $14.2M | $19.1M | $28.9M | $26.4M |
| Owner earnings? | $67.2M | -$69.2M | -$131.0M | -$138.6M | -$161.2M | -$166.4M |
| Free cash flow per share | – | $-0.99 | $-1.33 | $-1.26 | $-1.21 | $-1.20 |
| Capital allocation | ||||||
| Dividends paid | – | – | – | – | – | – |
| Share repurchases | – | – | – | – | – | – |
| Diluted shares | – | 62.1M | 87.8M | 94.6M | 109.2M | 116.2M |
| Share count change? | – | – | 41.4% | 7.7% | 15.5% | 6.4% |
| Balance sheet | ||||||
| Cash and equivalents | $28.4M | $142.7M | $60.0M | $66.4M | $69.5M | $112.3M |
| Short-term investments | $161.9M | $342.5M | $306.2M | $270.5M | $188.4M | $230.9M |
| Total debt | – | – | – | – | – | – |
| Net debt | – | – | – | – | – | – |
| Shareholders' equity | $38.6M | $344.7M | $249.5M | $253.1M | $199.5M | $346.2M |
Latest filings
| 2026-08-11 | 8-K | Earnings release |
| 2026-08-11 | 10-Q | Quarterly report |
| 2026-05-13 | 8-K | Earnings release |
| 2026-05-13 | 10-Q | Quarterly report |
| 2026-04-17 | DEF 14A | Proxy statement |
| 2026-03-05 | 8-K | Earnings release |
| 2026-03-05 | 10-K | Annual report |
| 2026-01-08 | 8-K | Earnings release |
| 2025-11-04 | 8-K | Earnings release |
| 2025-11-04 | 10-Q | Quarterly report |
More from our coverage
- MSFTPlatforms8.4MicrosoftThe most entrenched software franchise in the enterprise, now spending its cash flow on AI capacity; a great business we would own with a margin of safety, not at any price.Base value $410.29
- NVDAAI infrastructure8.4NVIDIAThe best business in technology at the top of its cycle: the moat is CUDA as much as silicon, but today's margins are a peak, not a floor.Base value $104.32
- AAPLHardware7.6AppleOne of the highest-quality businesses in the world growing in the low single digits; the price usually assumes more growth than the numbers show.Base value $134.27
- GOOGLPlatforms7.4AlphabetSearch pays for everything, and AI is both its biggest threat and its biggest opportunity; the price has to allow for search being worth less than it was.Base value $209.60
- NOWSoftware7.4ServiceNowA rare enterprise platform still growing above 20% with high retention; the free cash flow is real but stock pay takes a large share of it.Base value $189.13
- ADBESoftware7.4AdobeSuperb margins and a shrinking share count, priced for decline; the question is whether AI makes Adobe's tools more valuable or makes them unnecessary.Base value $449.35
